Simulations Plus, Inc. (NASDAQ:SLP) CEO Walter S. Woltosz sold 18,500 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $15.78, for a total transaction of $291,930.00. Following the sale, the chief executive officer now owns 5,610,916 shares of the company’s stock, valued at $88,540,254.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Shares of Simulations Plus, Inc. (NASDAQ:SLP) traded up $0.05 during midday trading on Friday, reaching $15.60. 32,695 shares of the company traded hands, compared to its average volume of 39,167. The company has a market capitalization of $269.64, a price-to-earnings ratio of 45.74 and a beta of -0.73. Simulations Plus, Inc. has a 12 month low of $8.81 and a 12 month high of $17.45.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Tuesday, November 14th. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.01. The company had revenue of $6.30 million during the quarter, compared to analyst estimates of $5.01 million. Simulations Plus had a net margin of 23.94% and a return on equity of 23.95%. analysts forecast that Simulations Plus, Inc. will post 0.4 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Monday, November 20th. Investors of record on Monday, November 13th were given a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 1.54%. This is a positive change from Simulations Plus’s previous quarterly dividend of $0.05. The ex-dividend date of this dividend was Friday, November 10th. Simulations Plus’s payout ratio is 72.73%.

Several brokerages recently issued reports on SLP. BidaskClub upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating in a research report on Thursday, October 5th. Zacks Investment Research lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Wednesday, September 20th.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP boosted its position in shares of Simulations Plus by 4.7% in the first quarter. Dimensional Fund Advisors LP now owns 368,194 shares of the technology company’s stock worth $4,326,000 after purchasing an additional 16,362 shares during the period. KCG Holdings Inc. bought a new position in shares of Simulations Plus in the first quarter worth approximately $152,000. Goldman Sachs Group Inc. bought a new position in shares of Simulations Plus in the first quarter worth approximately $600,000. Schwab Charles Investment Management Inc. bought a new position in shares of Simulations Plus in the second quarter worth approximately $241,000. Finally, Rice Hall James & Associates LLC boosted its position in shares of Simulations Plus by 1.0% in the second quarter. Rice Hall James & Associates LLC now owns 83,819 shares of the technology company’s stock worth $1,035,000 after purchasing an additional 869 shares during the period. Institutional investors own 33.41% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/12/02/simulations-plus-inc-slp-ceo-walter-s-woltosz-sells-18500-shares.html.

Simulations Plus Company Profile

Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

Insider Buying and Selling by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.